Former Elan CEO Takes Helm of Expanded Serenus Biotherapeutics Board of Directors

Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company bridging the divide between the world’s leading pharmaceutical markets and the growing demand for access to innovative therapies in the emerging nations of Africa, announced G. Kelly Martin, director of Malin Corporation plc and former CEO of Elan Corporation, began serving as Chairman of Serenus Biotherapeutics today.